Clinical Trial

Outcomes of Double-face Augmentation Urethroplasty

Study acronym: BMG
Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 27, 2026 (before its estimated August 10, 2026 completion). Its status may not reflect the trial's current state.
Summary
Combined dorsal and ventral onlay augmentation for bul¬bar urethral reconstruction. Nontraumatic near-obliterative bulbar urethral strictures (BUS) of \<2 cm in length can be managed with non-transecting anastomotic bulbar urethroplasty or augmented anastomotic urethroplasty. However, if the obliterative stricture segment is \>2 cm and the urethral caliber is \<6F, augmentation with a single graft may not be sufficient. We present our initial experience with the double-face augmentation urethroplasty technique using buccal mucosal graft for near-obliterative bulbar urethral strictures through ventral or one-sided dorsal perineal approach and the analysis of the short-term outcomes of this technique.
Trial Details
NCT Number NCT07436819
Lead Sponsor Menoufia University
Conditions Urethral Stricture, Anterior, Urethral Stricture Disease
Enrollment 30 participants
Start Date 2025-02-01
Primary Completion 2026-08-10 (estimated)
Study Completion 2027-02-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-27